Pharmaco-Invasive Strategy With Half-Dose Tenecteplase in Patients With STEMI: Prespecified Pooled Analysis of Patients Aged ≥75 Years in STREAM-1 and 2 - Bainey, Kevin R.; Welsh, Robert C.; Zheng, Yinggan; Arias-Mendoza, Alexandra; Ristic, Arsen D.; Averkov, Oleg V.; Lambert, Yves; Kerr Saraiva, José F.; Sepulveda, Pablo; Rosell-Ortiz, Fernando; French, John K.; Musić, Ljilja B.; et al. (Circulation. Cardiovascular interventions, 2024)
Keywords: Age Factors; Aged; Aged, 80 and over; Coronary Angiography; Female; Fibrinolytic Agents - administration & dosage; Fibrinolytic Agents - adverse effects; Humans; Intracranial Hemorrhages - chemically induced; Male; Percutaneous Coronary Intervention - adverse effects; Percutaneous Coronary Intervention - mortality; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; ST Elevation Myocardial Infarction - diagnosis; ST Elevation Myocardial Infarction - diagnostic imaging; ST Elevation Myocardial Infarction - drug therapy; ST Elevation Myocardial Infarction - mortality; ST Elevation Myocardial Infarction - therapy; Tenecteplase - administration & dosage; Tenecteplase - adverse effects; Thrombolytic Therapy - adverse effects; Time Factors; Tissue Plasminogen Activator - administration & dosage; Tissue Plasminogen Activator - adverse effects; Treatment Outcome; fibrinolysis; percutaneous coronary intervention; reperfusion; intracranial hemorrhages; myocardial infarction